The role of quantitative estrogen receptor status in predicting tumor response at surgery in breast cancer patients treated with neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

The role of quantitative estrogen receptor status in predicting tumor response at surgery in breast cancer patients treated with neoadjuvant chemotherapy

Published:2017-05-02 Issue:2 Volume:164 Page:285-294
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Raphael Jacques,Gandhi Sonal,Li Nim,Lu Fang-I,Trudeau Maureen

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/article/10.1007/s10549-017-4269-6/fulltext.html

Reference32 articles.

1. Martei YM, Matro JM (2015) Identifying patients at high risk of breast cancer recurrence: strategies to improve patient outcomes. Breast Cancer 8(7):337–343 (Dove Med Press)

2. Kaufmann M, von Minckwitz G, Smith R, Valero V, Gianni L, Eiermann W, Howell A, Costa SD, Beuzeboc P, Untch M, Blohmer JU, Sinn HP, Sittek R, Souchon R, Tulusan AH, Volm T, Senn HJ (2003) International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations. J Clin Oncol 21(13):2600–2608

3. Osako T, Nishimura R, Okumura Y, Toyozumi Y, Arima N (2012) Predictive significance of the proportion of ER-positive or PgR-positive tumor cells in response to neoadjuvant chemotherapy for operable HER2-negative breast cancer. Exp Ther Med 3(1):66–71 Epub 2011 Oct 3

4. Brouckaert O, Paridaens R, Floris G, Rakha E, Osborne K, Neven P (2013) A critical review why assessment of steroid hormone receptors in breast cancer should be quantitative. Ann Oncol 24(1):47–53

5. Faneyte IF, Schrama JG, Peterse JL, Remijnse PL, Rodenhuis S, van de Vijver MJ (2003) Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome. Br J Cancer 88:406–412

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative Biomarkers, Genomic Assays, and Demographics Associated with Breast-Conserving Surgery Following Neoadjuvant Therapy in Early-Stage, Hormone Receptor-Positive, HER-Negative Breast Cancer;Annals of Surgical Oncology;2024-09-09

2. Development and Assessment of a Novel Core Biopsy-Based Prediction Model for Pathological Complete Response to Neoadjuvant Chemotherapy in Women with Breast Cancer;International Journal of Environmental Research and Public Health;2023-01-16

3. Development and assessment of a novel core biopsy-based prediction model for pathological complete response to neoadjuvant chemotherapy in breast cancer;2022-09-22

4. Development, verification, and comparison of a risk stratification model integrating residual cancer burden to predict individual prognosis in early-stage breast cancer treated with neoadjuvant therapy;ESMO Open;2021-10

5. Neoadjuvant chemotherapy in hormone receptor-positive/HER2-negative early breast cancer: When, why and what?;Critical Reviews in Oncology/Hematology;2021-04